Commercialising science

How well does New Zealand commercialise its science? Are there missing bits to our system still, or is the creation of Callaghan Innovation the last big block? What are the relevant measures of success?

This is the fourteenth Moxie session, held Tuesday 1 April 2014 in Auckland.

Interview by Glenn Williams.

Speakers

David Downs

LinkedIn

Interesting history

Russell O’Brien

LinkedIn

Better incubation

Brent Ogilvie

LinkedIn

An investor’s perspectives

Join the discussion

Your email address will not be published. Required fields are marked *